Synchronous Data Flow: Describing Signal Processing Algorithm for Parallel Computation

Edward A. Lee,D. Messerschmitt

Abstract:

What problem does this paper attempt to address?

Randomized clinical trial comparing three local hemostatic agents for dental extractions in patients under chronic anticoagulant therapy - A comparative study

Sebastian Ariel Puia,Ezequiel Matias Hilber,Matias Garcia-Blanco,SebastianAriel Puia,EzequielMatias Hilber

DOI: https://doi.org/10.4103/ams.ams_276_20

2020-01-01

Annals of Maxillofacial Surgery

Abstract:INTRODUCTION: Oral anticoagulants are widely used worldwide for many systemic diseases. Recent oral surgical protocols suggest that therapeutic levels of the anticoagulant drug should be maintained for simple dental extractions because bleeding complications could be managed with proper local hemostasis. The aim of the present study was to compare bleeding complication of three different local hemostatic agents for dental extractions without interrupting drug administration in patients undergoing oral Vitamin K antagonist chronic anticoagulant therapy.MATERIAL AND METHODS: Randomized control trial of three hemostatic agents for dental extractions, in patients under oral anticoagulant therapy without drug interruption. The present study included 240 patients with international normalized ratio between 1.5 and 3.5. Patients took their anticoagulation drug normally. A single surgeon performed calibrated simple dental extractions and applied a plug of bismuth subgallate (BS), fibrin tissue adhesive (FTA) or microfibrillar collagen (MC), assigned randomly. Statistical analysis of bleeding between the groups was performed using the Chi-square test.RESULTS: There was no hemorrhagic complication in the BS group, and only one in the FTA group. However, in the MC group, 10 patients (12.5%) suffered postoperative bleeding. Data analysis showed statistical differences between the MC group and the other two groups (<i>P</i> < 0.05).DISCUSSION: BS and FTA showed similar clinical effectiveness and were more effective than MC for the control of postoperative bleeding in oral anticoagulated patients.
Effect of oral tranexamic acid on postoperative bleeding in spinal surgery: a randomized controlled trial

Saeed Kargar-Soleimanabad,Aynoor Khormali,Farnaz Godazandeh,Sajjad Najafi

DOI: https://doi.org/10.1097/MS9.0000000000001820

2024-06-10

Abstract:Background and objective: This study aimed to investigate the effect of oral administration of tranexamic acid (TXA) on reducing intraoperative bleeding during spinal surgeries. Method: The study was a single-center, double-blind, randomized, placebo-controlled clinical trial. Participants were individuals over 20 years old who underwent spinal surgery. Patients received 1.5 g of TXA orally, 2 h before surgery. Intraoperative bleeding volume, blood volume in the drain after surgery, length of hospital stays after surgery, incidence of nausea or vomiting, decrease in hemoglobin (Hb) level, and postoperative coagulation test results were evaluated in each group. Results: In this study, patients were assigned to each study group based on inclusion and exclusion criteria. The mean age of patients was 69.6±6.47 years, and 65% were male. There was no significant difference in age, sex, pre and postoperative Hb levels, prothrombin time (PT), or international normalized ratio (INR) between the study groups. Intraoperative bleeding volume and blood volume in the drain after surgery were significantly lower in the TXA group. Additionally, the length of hospital stay after surgery was significantly shorter in the TXA group. The incidence of nausea or vomiting was significantly higher in the TXA group. Furthermore, postoperative partial thromboplastin time (PTT) was significantly higher in the TXA group compared to the placebo group. Conclusion: Oral administration of TXA before spinal surgery leads to a significant reduction in intraoperative and postoperative bleeding without significant adverse effects and also reduces the length of hospital stay.
The effect of different hemostatic agents following dental extraction in patients under oral antithrombotic therapy: a network meta-analysis

Basel Mahardawi,Sirimanas Jiaranuchart,Sirida Arunjaroensuk,Kevin A. Tompkins,Anupap Somboonsavatdee,Atiphan Pimkhaokham

DOI: https://doi.org/10.1038/s41598-023-39023-7

IF: 4.6

2023-08-04

Scientific Reports

Abstract:This network meta-analysis was done to thoroughly evaluate the available literature on the use of different hemostatic agents for dental extraction in patients under oral antithrombotic therapy, aiming to identify the agent with the best/worst performance in bleeding control. Considering that such patients have a higher risk of bleeding, choosing the right hemostatic is essential. Twenty-three randomized clinical trials articles were included after completing the literature search. Cyanoacrylate tissue adhesive showed a reduction in the odds of postoperative bleeding events compared with conventional methods (i.e., gauze/cotton pressure, sutures), with a tendency toward a statistical significance (OR 0.03, P = 0.051). Tranexamic acid was the only agent that demonstrated a significantly lower risk of developing postoperative bleeding events (OR 0.27, P = 0.007). Interestingly, chitosan dental dressing and collagen plug had the shortest time to reach hemostasis. However, they ranked last among all hemostatic agents, regarding bleeding events, revealing higher odds than conventional measures. Therefore, it is concluded that the use of cyanoacrylate tissue adhesive and tranexamic acid gives favorable results in reducing postoperative bleeding events following dental extractions. Although chitosan dental dressing and collagen exhibited a faster time to reach hemostasis, they led to a higher occurrence of bleeding events.

multidisciplinary sciences
Management of empyema cavity with the vacuum-assisted closure device.

K. A. Varker,T. Ng

DOI: https://doi.org/10.1016/J.ATHORACSUR.2004.10.040

2006-02-01

Abstract:
Cytogenetic Variability in Genus Odontocheila (Coleoptera, Cicindelidae): Karyotypes, C-Banding, NORs and Localisation of Ribosomal Genes of O. Confusa and O. Nodicornis

S. J. Proença,Artur R. M. Serrano,M. COLLARES-PEREIRA

DOI: https://doi.org/10.1023/A:1016221430207

2002-04-01

Genetica

Abstract:
Post-stroke disability and its predictors among Nigerian stroke survivors.

O. Oyewole,M. Ogunlana,K. Oritogun,C. Gbiri

DOI: https://doi.org/10.1016/j.dhjo.2016.05.011

IF: 4.615

2016-10-01

Disability and Health Journal

Abstract:
Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial

Hao-Yang Wang,Liu Wang,Ze-Yu Luo,Duan Wang,Xin Tang,Zong-Ke Zhou,Fu-Xing Pei

DOI: https://doi.org/10.1186/s12891-019-2885-5

IF: 2.562

2019-10-25

BMC Musculoskeletal Disorders

Abstract:Abstract Background To assess the efficacy and safety of intravenous and subsequent long-term oral tranexamic acid (TXA) following total knee arthroplasty (TKA) without a tourniquet. Methods In this double-blinded trial, 118 patients undergoing primary TKA were randomized into two groups: the patients in group A received intravenous TXA at 20-mg/kg 10 min before the surgery and 3 h postoperatively, and then oral 1 g TXA from postoperative day (POD) 1 to POD 14, and the patients in group B received intravenous TXA at 20-mg/kg 10 min before surgery and 3 h postoperatively, and then oral 1 g placebo from postoperative day (POD) 1 to POD 14. The primary outcome was total blood loss. Secondary outcomes included ecchymosis area and morbidity, postoperative transfusion, postoperative laboratory values, postoperative knee function and length of hospital stay. Complications, and patient satisfaction were also recorded. Results The mean total blood loss was lower in Group A than in Group B (671.7 ml vs 915.8 ml, P = 0.001). There was no significant difference in the transfusion rate between the two groups. Group A had a higher hemoglobin than Group B on POD 3 (106.0 g/L vs 99.7 g/L, P = 0.001). However, no significant difference was found for Hb or hematocrit on POD 1 or POD 14 between the two groups. Patients in Group A had less ecchymosis morbidity (7 vs 38, P = 0.001), smaller ecchymosis area (1.6 vs 3.0, P = 0.001) than Group B. The blood coagulation level as measured by fibrinolysis (D-Dimer) was lower in Group A than in Group B on POD 1 and POD 3 (4.6 mg/L vs. 8.4 mg/L, respectively, P = 0.001; 1.5 mg/L vs. 3.3 mg/L, respectively, P = 0.001). However, there was no significant difference on POD 14, and the fibrin degradation products showed the same trend. Patients in Group A had less swelling than those in Group B on POD 3 and POD 14. The circumference of the knee was 43.1 cm vs. 46.1 cm (POD 3, P = 0.001) and 41.4 cm vs. 44.9 cm (POD 14, P = 0.001) in Group A vs Group B, respectively. Nevertheless, the circumference of the knee in the two groups was similar on POD 1 and POD 3 M. No significant differences were identified in knee function, pain score, or hospital stay. No significant differences were identified in thromboembolic complications, infection, hematoma, wound healing and patients satisfaction between the two groups. Conclusion Intravenous and subsequent long-term oral TXA produced less blood loss and less swelling and ecchymosis compared with short-term TXA without increasing the risk of complications. Trial registration The trial was registered in the Chinese Clinical Trial Registry ( ChiCTR-IPR-17012264 ).

orthopedics,rheumatology
MEG and EEG in epilepsy: is there a difference?

C. Guy,S. Walker,G. Alarcón,C. Binnie,P. Chesterman,P. Fenwick,S. Smith

DOI: https://doi.org/10.1088/0967-3334/14/4A/018

1993-11-01

Physiological Measurement

Abstract:Interictal epileptiform activity recorded by scalp EEG, foramen ovale electrodes and MEG is discussed. Gross differences in waveform between the electric and magnetic records are discussed in the light of intracranial depth recordings.
Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery

S Sindet-Pedersen,G Ramström,S Bernvil,M Blombäck

DOI: https://doi.org/10.1056/NEJM198903303201305

1989-03-30

Abstract:We carried out a placebo-controlled, double-blind, randomized study of the hemostatic effect of tranexamic acid mouthwash after oral surgery in 39 patients receiving anticoagulant agents because of the presence of cardiac valvular stenosis, a prosthetic cardiac valve, or a vascular prosthesis. Surgery was performed with no change in the level of anticoagulant therapy, and treatment with the anticoagulant agent was continued after surgery. Before it was sutured, the operative field was irrigated in 19 patients with 10 ml of a 4.8 percent aqueous solution of tranexamic acid (an inhibitor of fibrinolysis) and in 20 patients with a placebo solution. For seven days thereafter, patients were instructed to rinse their mouths with 10 ml of the assigned solution for two minutes four times a day. There were no significant differences between the two treatment groups in base-line variables, including the level of anticoagulation at the time of surgery. Eight patients in the placebo group had a total of 10 postoperative bleeding episodes, whereas only 1 patient in the tranexamic acid group had a bleeding episode (P = 0.01). There were no systemic side effects. We conclude that local antifibrinolytic therapy is effective in preventing bleeding after oral surgery in patients who are being treated with anticoagulants.
Application of Tranexamic Acid in Total Knee Arthroplasty – Prospective Randomized Trial

Joao Paulo Fernandes Guerreiro,Bruno Scatolon Badaro,Jose Rodolfo Martines Balbino,Marcus Vinicius Danieli,Alexandre Oliveira Queiroz,Daniele Cristina Cataneo

DOI: https://doi.org/10.2174/1874325001711011049

2017-08-29

The Open Orthopaedics Journal

Abstract:Background: The use of tranexamic acid (TXA) in total knee arthroplasty (TKA) has shown good results. Bleeding may cause local complications consequently greater pain and reduced function postoperatively. No study has related the use of TXA to these facts. Objective: The aim was to evaluate the effects of TXA haemoglobin, Western Ontario and McMaster Universities Index (WOMAC), pain intensity and flexion gain after TKA. Methods: 43 patients were randomized and then underwent TKA. TXA was applied to 22 of these patients before closure of the joint capsule. Haemoglobin measurements (mg/dL) were taken preoperatively and 24 and 48 hours after surgery. The WOMAC questionnaire and pain visual analogue scale (VAS) were applied, and flexion gain was measured up to the second postoperative month. Statistical analysis compared the results to determine whether there were differences between the groups for each of the evaluated times. Results: There were differences in favour of the drug 48 hours postoperatively for the haemoglobin variable (p = 0.01), in pain evaluation, 24 and 48 hours, postoperatively (p < 0.01) and in flexion gain, 24 hours after surgery (p = 0.03). There were no significant differences between the groups in the haemoglobin evaluation 24 hours postoperatively, in pain assessment 7 days, 21 days and 2 months, postoperatively, in flexion gain 48 hours, 7 days, 21 days and 2 months, postoperatively and in WOMAC after 2 months. Conclusion: In addition to reducing bleeding, topical TXA improved pain and increased flexion gain in the first hours after TKA. Trial Registration: RBR-9b4qgq
Efficacy and Safety of Oral Tranexamic Acid vs. Other Routes in Total Joint Arthroplasty: A Systematic Review and Network Meta-Analysis

Mohammad Poursalehian,Mahboobeh Tajvidi,Rezvan Ghaderpanah,Mohammad Soleimani,Seyedeh Melika Hashemi,Amir Reza Kachooei

DOI: https://doi.org/10.2106/JBJS.RVW.23.00248

2024-06-18

Abstract:Background: Total joint arthroplasty (TJA) is often associated with significant blood loss, leading to complications such as acute anemia and increased risk of infection and mortality. Tranexamic acid (TXA), an antifibrinolytic agent, has been recognized for effectively reducing blood loss during TJA. This systematic review and network meta-analysis aims to evaluate the efficacy and safety of oral TXA compared with other administration routes in TJA. Methods: Adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a comprehensive literature search was conducted across multiple databases, including PubMed, Scopus, Embase, and Web of Science, focusing on randomized clinical trials involving oral TXA in TJA. The studies were assessed for quality using the Cochrane risk assessment scale. Data synthesis involved network meta-analyses, comparing outcomes including hemoglobin drop, estimated blood loss (EBL), transfusion rate, and deep vein thrombosis (DVT) rate. Results: Our comprehensive literature search incorporated 39 studies with 7,538 participants, focusing on 8 TXA administration methods in TJA. The combination of oral and intra-articular (oral + IA) TXA markedly reduced hemoglobin drop more effectively than oral, intravenous (IV), and IA alone, but the difference was not significant. Oral + IA TXA significantly reduced EBL more effectively than oral + IV, IA + IV, and oral, IV, and IA alone. Perioperative transfusion rates with oral + IA TXA was significantly lower than that of oral, IA, and IV alone. The DVT rate with oral + IA was significantly lower than that with all other routes, including oral + IV, IA + IV, and oral, IA, and IV alone. Conclusion: Oral TXA, particularly in combination with IA administration, demonstrates significantly higher efficacy in reducing blood loss and transfusion rates in TJA, with a safety profile comparable with that of other administration routes. The oral route, offering lower costs and simpler administration, emerges as a viable and preferable option in TJA procedures. Level of evidence: Level I. See Instructions for Authors for a complete description of levels of evidence.
Comparison of oral versus intravenous tranexamic acid in total knee and hip arthroplasty: A GRADE analysis and meta-analysis

Changjiao Sun,Xiaofei Zhang,Lianxu Chen,Jiuzheng Deng,Qi Ma,Xu Cai,Huadong Yang

DOI: https://doi.org/10.1097/MD.0000000000022999

2020-10-30

Abstract:Background: The efficacy and safety of oral tranexamic acid (TXA) remain controversial because of the small number of clinical studies. The aim of the present study was to compare the efficacy and safety of oral TXA with intravenous TXA in patients undergoing total hip arthroplasty and total knee arthroplasty in a systematic review and meta-analysis. Methods: We conducted a meta-analysis to identify randomized controlled trials (RCTs) involving oral and intravenous TXA in total hip arthroplasty and total knee arthroplasty up to December 2019 by searching databases including PubMed, Web of Science, Embase, the Cochrane Controlled Trials Register, the Cochrane Library China Biology Medicine, China National Knowledge Infrastructure, China Science and Technology Journal Database and Wanfang. The mean difference or standard mean difference was used to assess continuous outcomes such as hemoglobin (Hb) drop, total blood loss, drain blood loss, and length of hospital stay, with a 95% confidence interval. Relative risks with a 95% confidence interval were used to assess dichotomous outcomes such as transfusion rate and the incidence of deep venous thrombosis and calf muscular vein thrombosis. Review Manager was used for the meta-analysis. Results: Ten RCTs containing 1080 participants met the inclusion criteria. We found no significant differences in terms of the average Hb drop (P = .60), total blood loss (P = .60), transfusion rate (P = .99), drain blood loss (P = .91), length of hospital stay (P = .95), and the incidence of deep venous thrombosis (P = .55) and calf muscular vein thrombosis (P = .19) between oral and IV TXA. Conclusions: Compared with the IV TXA, oral TXA has similar effects on reducing the Hb drop, total blood loss, transfusion rate, drain blood loss, and length of hospital stay without increasing the risk of calf muscular vein thrombosis and deep venous thrombosis. Furthermore, oral TXA is easy to access and administer, which decreases the workload of nurses and even delivers cost-saving benefits to the health care system. We thus conclude that oral TXA may be an optimal approach in total joint arthroplasty. However, more high-quality and multicenter RCTs are still needed to confirm our conclusions. Registration: The current meta-analysis was registered on PROSPERO (International Prospective Register of Systematic Reviews), and the registration number was CRD42018111291.
Oxidation of polychlorinated benzenes by genetically engineered CYP101 (cytochrome P450(cam)).

J. P. Jones,Ellen J. O’Hare,L. Wong

DOI: https://doi.org/10.1046/J.1432-1327.2001.02018.X

2001-03-01

European Journal of Biochemistry

Abstract:Polychlorinated benzenes are recalcitrant environmental pollutants primarily because they are resistant to attack by dioxygenases commonly used by micro-organisms for the biodegradation of aromatic compounds. We have investigated the oxidation of polychlorinated benzenes by mutants of the haem mono-oxygenase CYP101 (cytochrome P450(cam)) from Pseudomonas putida with the aim of generating novel systems for their biodegradation. Wild-type CYP101 had low activity for the oxidation of dichlorobenzenes and trichlorobenzenes to the chlorophenols, but no products were detected for the heavily chlorinated benzenes. Increasing the active-site hydrophobicity with the Y96F mutation increased the activity up to 100-fold, and both pentachlorobenzene and hexachlorobenzene were oxidized slowly to pentachlorophenol. Decreasing the space available at the top of the active site with the F87W mutation to force the substrate to be bound closer to the haem resulted in a further 10-fold increase in activity with most substrates. Introducing the F98W mutation, also at the top of the active site, decreased the NADH-turnover rates but increased the coupling efficiencies, and > 90% coupling was observed for 1,3-dichlorobenzene and 1,3,5-trichlorobenzene with the F87W--Y96F--F98W mutant. The V247L mutation generally increased the NADH-turnover rates, and the F87W--Y96F--V247L mutant showed reasonably fast NADH turnover (229 min(-1)) with the highly insoluble pentachlorobenzene without the need for surfactants or organic cosolvents. As all chlorophenols are degraded by micro-organisms, novel biodegradation systems could be constructed in which CYP101 mutants convert the inert polychlorinated benzenes to the phenols, which are then readily degraded by natural pathways.
Cancer prevention by carotenoids. Mechanistic studies in cultured cells.

J. Bertram

IF: 6.499

Annals of the New York Academy of Sciences

Abstract:In 10T1/2 cells several dietary carotenoids have been shown to be capable of inhibiting carcinogen-induced neoplastic transformation. Their action appears qualitatively similar to the previously documented action of retinoids in this cell system; however, higher concentrations (10-1000-fold) are required. Both types of compound were found to strongly upregulate gap junctional intercellular communication, and these activities were statistically correlated. Upregulation of gap junctional intercellular communication was caused by the increased expression of connexin 43, a structural protein of the gap junction. Increased junctional communication has been proposed to be mechanistically linked to inhibition of transformation in 10T1/2 cells. In this model the gap junction serves as a conduit for growth regulatory signals from normal to initiated cells. These putative signals act to suppress transformation of the carcinogen-initiated cell.
[Acceptance and future of the internet for clinical trials in Germany--results of a survey].

W. Kuchinke,H. Eich,C. Ohmann

Abstract:
Effectiveness of local hemostatic to prevent bleeding in dental patients on anticoagulation: A systematic review and network meta-analysis

Johana Alejandra Moreno-Drada,Lucas Guimarães Abreu,Patrícia Azevedo Lino,Maria Auxiliadora Parreiras Martins,Isabela Almeida Pordeus,Mauro Henrique Nogueira Guimarães de Abreu

DOI: https://doi.org/10.1016/j.jcms.2021.04.014

Abstract:This study aimed to determine the effectiveness of hemostatic protocols to prevent bleeding in dental procedures among individuals undergoing oral anticoagulation therapy. A systematic review and network meta-analysis were accomplished. Searches of literature and grey literature were performed in different electronic databases. Clinical trials were considered as part of the inclusion criteria. Data extraction and assessment of the risk of bias of the included articles were performed. Assessment of the certainty of evidence was also performed. As results we find that the N-butyl-2-cyanoacrylate [RR -35.00 (95% CI - 107.12, -5.78)], calcium sulfate (CaSO4) [RR -5.62 (95% CI -11.41, -1.03)], and tranexamic acid (TXA) [RR -3.46 (95% CI -7.63, -0.77)] showed beneficial effects compared to placebo. However, only TXA presented beneficial effects with moderate certainty evidence. N-butyl-2-cyanoacrylate and CaSO4 presented very low certainty evidence. In the comparisons between the hemostatic agents, no differences were observed. For the mean bleeding time, no significant difference in the comparisons was observed as well. Concluding, bleeding events in individuals on oral anticoagulation decreased with the use of TXA compared to placebo. N-butyl-2-cyanoacrylate and CaSO4 were also superior to placebo, but the certainty of evidence was low. For the mean bleeding time, no significant difference in hemostatic agents was observed.
Evaluation of Healing Process and Blood Sugar Level Following Local Anesthetic Infiltration with and Without Vasoconstrictor for Extraction of Maxillary Teeth in Diabetic Patients: Double Blind Randomized Controlled Clinical Trial

Tarek Abd Elbary Abd Elatife Saad

DOI: https://doi.org/10.21608/ejhm.2023.305757

2023-04-01

The Egyptian Journal of Hospital Medicine

Abstract:Background: Dental extractions are routinely performed in dental offices, and the local anesthetics most frequently employed are combined with vasoconstrictors, which have undeniable benefits. Vasoconstrictors boost the quality of anesthesia, lessen toxic effects, reduce the concentration required, and reduce blood loss during surgical operations. Objective: The aim of the current study was to evaluate healing of the extraction socket and the glycemic levels before, and after injection of local anesthesia with and without vasoconstrictor in diabetic patients. Patients and methods: A total of 40 patients with controlled diabetes requiring dental extraction were randomly and equally allocated to either group A (anesthetized with Mepivacaine hydrochloride 30 mg (3%) without vasoconstrictor) or group B (anesthetized with Mepivacaine hydrochloride 20 mg (2%) with vasoconstrictor Levonordefrin hydrochloride 0.06 mg). The involved tooth was extracted in an atraumatic manner. Blood glucose level was recorded prior to and 30 minutes following extraction and healing of extraction socket was assessed at 24 hours, 4-, 7-, 14- and 21-days using Landry wound healing index. Results: Regarding healing scores results showed no statistically significant difference between groups A and B at 24 hour and 21-day period, however group A showed a statistically significant faster healing than group B at 4, 7, 14 days period with P values 0.091, 0.027 and 0.035, respectively. While results for blood glucose level showed statistically significant difference in the same group before and after local anesthesia injection (P>0.001); moreover, after administration of local anesthesia group B showed statistically significant higher blood glucose level than did group A (P=0.04). Conclusion: Vasoconstrictor present in local anesthetic elevate blood glucose level and may retard extraction socket wound healing with in the first 2 weeks following extraction; however, it is still safe to use local anesthesia with vasoconstrictor with controlled diabetic patients.
Comparison of two hemostatic agents in patients receiving anticoagulants without altering medication dosage

Hala R. Ragab,Lydia N. Melek,Hala Ragab,Lydia Melek

DOI: https://doi.org/10.21608/edj.2019.74763

2019-10-01

Egyptian Dental Journal

Abstract:Background: Patients under anticoagulant therapy who need tooth extraction, face the problem of intraoperative and postoperative bleeding which may be difficult to control. Some surgeons use the option of stopping the medication or altering its dose for three to four days preoperatively to obtain adequate hemostasis; however, this may carry the risk of thromboembolism. Objective: This study aims to compare the effect of Gelatamp and Chitosan in control of post-extraction bleeding and prevention of complications as dry socket in patients receiving anticoagulant therapy without altering the medication dose.Materials and Methods: Patients were divided into 2 equal groups each consisting of 20 patients. Patients of group 1 underwent extraction followed by insertion of Gelatamp (gelatine sponge with colloidal silver). Patients of group 2 underwent extraction followed by insertion of Chitosan as a local hemostatic agent. All patients were examined postoperatively for bleeding after 5 minutes, 30 minutes, 2 hours and after 24 hours.Results: Comparing the 2 groups in the different follow-up periods with regards to postoperative bleeding, a statistically significant difference was found between the Gelatamp and Chitosan groups at 5 minutes, 30 minutes and 2 hours post-extraction in favor of Gelatatmp, while the 2 groups showed a non-significant difference at 24 hours after extraction. At the time of suture removal, proper wound healing was found in patients of both groups with no signs of dry socket, inflammation or infection.Conclusion: Both Gelatamp and Chitosan have provided adequate control of bleeding in patients receiving anticoagulants without altering drug dosage, with Gelatamp showing superior hemostatic effect in the immediate post-extraction period.
The spatial dependency of shoulder muscular demands during upward and downward exertions

Alicia L. Nadon,Meghan E. Vidt,A. Chow,C. Dickerson

DOI: https://doi.org/10.1080/00140139.2015.1136697

IF: 2.5612

2016-02-25

Ergonomics

Abstract:Abstract Lifting and lowering are common occupational tasks contributing to shoulder injury risk. Quantifying task interaction with physical demand can precipitate better workstation designs. Nineteen university-aged males performed one-handed, submaximal upward/downward manual force exertions at 70 hand locations; unilateral electromyography (EMG) of 14 muscles was recorded. EMG across planes was evaluated with ANOVA. Predictive equations for muscle activity throughout the reach envelope were developed with stepwise regression. Total muscle activity (sum of individual muscle activity) was most sensitive to vertical hand location for upward exertions, where activation at superior locations was 192% of values for inferior locations. For upward exertions, activation differences for hand location occurred along all anatomical axes, and along anterior/posterior and superior/inferior axes for downward exertions. Predictive equations were non-linear, reflecting complex muscular demand with three-dimensional hand location. This work details foundational exposure data for lifting/lowering exertions. Results are applicable to workstation design to minimise occupational shoulder muscular demands. Practitioner Summary: Lifting and lowering in the workplace contribute to shoulder injury risk. Shoulder muscle activity magnitudes revealed a dependence on three-dimensional hand location in the reach envelope for a defined hand force. This information can inform evidence-based workstation designs that reduce shoulder muscular demands for numerous materials handling scenarios.
Effect of Multiple Doses of Oral Tranexamic Acid on Haemostasis and Inflammatory Reaction in Total Hip Arthroplasty: A Randomized Controlled Trial

Duan Wang,Yang Yang,Chuan He,Ze-Yu Luo,Fu-Xing Pei,Qi Li,Zong-Ke Zhou,Wei-Nan Zeng

DOI: https://doi.org/10.1055/s-0038-1676625

2018-12-31

Thrombosis and Haemostasis

Abstract:Abstract Tranexamic acid (TXA) reduces surgical blood loss and alleviates inflammatory response in total hip arthroplasty. However, studies have not identified an optimal regimen. The objective of this study was to identify the most effective regimen of multiple-dose oral TXA in achieving maximum reduction of blood loss and inflammatory response based on pharmacokinetic recommendations. We prospectively studied four multiple-dose regimens (60 patients each) with control group (group A: matching placebo). The four multiple-dose regimens included: 2-g oral TXA 2 hours pre-operatively followed by 1-g oral TXA 3 hours post-operatively (group B), 2-g oral TXA followed by 1-g oral TXA 3 and 7 hours post-operatively (group C), 2-g oral TXA followed by 1-g oral TXA 3, 7 and 11 hours post-operatively (group D) and 2-g oral TXA followed by 1-g oral TXA 3, 7, 11 and 15 hours post-operatively (group E). The primary endpoint was estimated blood loss on post-operative day (POD) 3. Secondary endpoints were thromboelastographic parameters, inflammatory components, function recovery and adverse events. Groups D and E had significantly less blood loss on POD 3, with no significant difference between the two groups. Group E had the most prolonged haemostatic effect, and all thromboelastographic parameters remained within normal ranges. Group E had the lowest levels of inflammatory cytokines and the greatest range of motion. No thromboembolic complications were observed. The post-operative four-dose regimen brings about maximum efficacy in reducing blood loss, alleviating inflammatory response and improving analgaesia and immediate recovery.

peripheral vascular disease,hematology

Synchronous Data Flow: Describing Signal Processing Algorithm for Parallel Computation

Randomized clinical trial comparing three local hemostatic agents for dental extractions in patients under chronic anticoagulant therapy - A comparative study

Effect of oral tranexamic acid on postoperative bleeding in spinal surgery: a randomized controlled trial

The effect of different hemostatic agents following dental extraction in patients under oral antithrombotic therapy: a network meta-analysis

Management of empyema cavity with the vacuum-assisted closure device.

Cytogenetic Variability in Genus Odontocheila (Coleoptera, Cicindelidae): Karyotypes, C-Banding, NORs and Localisation of Ribosomal Genes of O. Confusa and O. Nodicornis

Post-stroke disability and its predictors among Nigerian stroke survivors.

Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial

MEG and EEG in epilepsy: is there a difference?

Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery

Application of Tranexamic Acid in Total Knee Arthroplasty – Prospective Randomized Trial

Efficacy and Safety of Oral Tranexamic Acid vs. Other Routes in Total Joint Arthroplasty: A Systematic Review and Network Meta-Analysis

Comparison of oral versus intravenous tranexamic acid in total knee and hip arthroplasty: A GRADE analysis and meta-analysis

Oxidation of polychlorinated benzenes by genetically engineered CYP101 (cytochrome P450(cam)).

Cancer prevention by carotenoids. Mechanistic studies in cultured cells.

[Acceptance and future of the internet for clinical trials in Germany--results of a survey].

Effectiveness of local hemostatic to prevent bleeding in dental patients on anticoagulation: A systematic review and network meta-analysis

Evaluation of Healing Process and Blood Sugar Level Following Local Anesthetic Infiltration with and Without Vasoconstrictor for Extraction of Maxillary Teeth in Diabetic Patients: Double Blind Randomized Controlled Clinical Trial

Comparison of two hemostatic agents in patients receiving anticoagulants without altering medication dosage

The spatial dependency of shoulder muscular demands during upward and downward exertions

Effect of Multiple Doses of Oral Tranexamic Acid on Haemostasis and Inflammatory Reaction in Total Hip Arthroplasty: A Randomized Controlled Trial